Welcome to the CGTA Research Group

Our name stands for “CNS Gene therapy Translation Acceleration.”

Our goal is to bring gene therapies for rare Central Nervous System diseases into clinical trials and use as quickly and efficiently as possible.  Our first project is focused on developing a gene therapy for Huntington’s disease.



December, 2017:

Although our grant application submitted to the National Institute of Neurological Diseases and Stroke was not funded, we received sufficiently encouraging reviews that we are now planning on revising and re-submitting the application for the March, 2018 application cycle.  We believe that our proposed work is complementary to developments that are underway by commercial companies.

See our news page for more details.